Role of Andi-d in Dengue Fever: a Pilot Study

• Status: Completed
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is evaluate the role of anti-d in dengue fever.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Postgraduate Institute of Medical Education and Research
• Treatments: gamma-Globulins; Immunoglobulins, Intravenous; Rho(D) Immune Globulin

Criteria

inclusion criteria:

• fever and thrombocytopenia with/without bleeding manifestations

• dengue serology positive patients

• platelet count ≤ 20,000/mm3

• Rh positive patients

• willing to give written informed consent

exclusion criteria:

• dengue serology positive but platelet count > 20,000/mm3

• Rh negative patients

• pregnant females